Qureight
End-to-end imaging company for clinical trials with a focus on lung and heart disease.
$20MSeries B
Role not disclosedMV
Molten Ventures
Activity from announced rounds
Activity in this selectionUnited Kingdom · Oct 23, 2026 · Jan 1, 2026
Molten Ventures is the investment firm whose official portfolio includes Qureight, IMU Biosciences and FintechOS.
Recorded funding activity
Qureight develops imaging tools for clinical trials. IMU profiles immune systems using multi-omic data, while FintechOS supplies financial-product operations software. EIS, VCT and other specifically named vehicles remain separate.
- Rounds participated in
- 3
- Confirmed lead rounds
- — 3 roles undisclosed
- New companies
- 3 First participation on record · 0 follow-on
- Funding in participating rounds
- $113.6M 3 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
3 in this selectionIMU Biosciences
Profiles human immune systems using multi-omic analysis and machine learning for disease research.
$53MSeries A
Role not disclosedSatVu
Provides space-based thermal intelligence data for defense security and infrastructure monitoring
£30MSeries A
Role not disclosed